Vitamin D3 shows promise for immune support in HIV patients
NCT ID NCT07553052
First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times
Summary
This study looked at whether taking vitamin D3 for 3 months can lower inflammation and boost immune cells in people with HIV who are already on antiretroviral therapy. Twenty adults with early-stage HIV took vitamin D3 supplements. Researchers measured changes in inflammation markers and CD4 counts. The goal was to see if this simple addition could improve overall disease control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Voluntary Counseling and Testing (VCT) Clinic, Dr. Moewardi General Hospital, Surakarta, Indonesia
Surakarta, Central Java, 57126, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic help break meth addiction in people with HIV?
- Could a diabetes drug turn back the biological clock in HIV?
- New HIV prevention drug faces drug interaction test
- HIV counselors lead new push to offer prevention pills at family planning visits
- Could a vending Machine-Style kiosk curb HIV and overdose deaths in rural america?
- Village health workers lead new HIV prevention effort in lesotho